Ondansetron for the Treatment of Cocaine Dependence - 1
The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.
Drug Administration Schedule
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence|
- Cocaine use
|Study Start Date:||May 2001|
|Estimated Study Completion Date:||December 2002|
Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence and to determine the optimal dose of ondansetron.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00033085
|United States, Texas|
|University of Texas Hlth Sci Ctr San Ant|
|San Antonio, Texas, United States, 78284 7828|
|Principal Investigator:||John Roache, Ph.D.||University of Texas|